Researcher
Jeroen Geldof
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From22 Mar 2023 → Today
Publications
1 - 10 of 12
- SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study(2023)
Authors: Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, et al.
- The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study(2022)
Authors: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro- Iglesias, Tom Holvoet, et al.
Pages: 1676 - 1686 - Infliximab re-challenge : could it be an option in refractory IBD patients?(2022)Volume: 16
Authors: Marie Truyens, Eva Pijoan Comas, ELIEN GLORIEUS, Jeroen Geldof, Triana Lobatón Ortega
Pages: i315 - i316 - Apoptotic enteropathy, gluten intolerance, and IBD-like inflammation associated with lipotoxicity in DGAT1 deficiency–related diarrhea : a case report of a 17-year-old patient and literature review(2022)
Authors: Ellen Deolet, Bert Callewaert, Jeroen Geldof, Saskia Vande Velde, Myriam Van Winckel, Anne Hoorens
Pages: 785 - 791 - The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study(2021)Volume: 15
Authors: Marie Truyens, Cara De Galan, H Peeters, F Mesonero Gismero, A Elorza, P Torres, L Vandermeulen, A Jauregui Amezaga, R Ferreiro-Iglesias, T Holvoet, et al.
Pages: S302 - S302 - First results of the BELCOMID study : Belgian cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)(2021)Volume: 15
Authors: Jeroen Geldof, Marie Truyens, J Sabino, M Ferrante, T Hillary, A Van Laethem, K De Vlam, P Verschueren, Triana Lobatón Ortega, S Vermeire
Pages: S440 - S440 - Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic : results from a Belgian tertiary IBD unit(2021)Volume: 15
Authors: Goedele Dewitte, Jeroen Geldof, Marie Truyens, Triana Lobatón Ortega
Pages: S610 - S611 - Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study(2021)Volume: 9
Authors: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro-Iglesias, Tom Holvoet, et al.
Pages: 554 - 555 - Effectiveness of ustekinumab in refractory Crohn's disease : a real-life experience in a tertiary referral centre(2020)Volume: 14
Authors: Marie Truyens, Jeroen Geldof, G. Dewitte, ELIEN GLORIEUS, Triana Lobatón Ortega
Pages: S330 - S330 - The impact of vedolizumab on extra-intestinal manifestations in inflammatory bowel disease patients : a real-life experience of a single-centre cohort(2020)Volume: 14
Authors: Marie Truyens, Jeroen Geldof, G. Dewitte, ELIEN GLORIEUS, Gaëlle Varkas, Triana Lobatón Ortega
Pages: S546 - S547